Osteoclast function and its control
- PMID: 8311941
- DOI: 10.1113/expphysiol.1993.sp003721
Osteoclast function and its control
Abstract
Bone resorption appears to be dependent on a range of processes. It requires an adequate number of osteoclasts to access bone mineral. These osteoclasts must be activated by a mechanism which is dependent upon prior osteoblastic stimulation. A range of factors then contribute to the formation of a functionally effective resorptive hemivacuole. These entail osteoclast adhesion to the bone surface leading to the formation of a sealing zone. Only then can subsequent processes such as H+ ion transport, enzyme secretion and matrix digestion become effective. Thus, any one process is potentially limiting to resorption and is a potential target for regulation. Long-range regulation takes place through the action of hormones, of which the mode of action of calcitonin has been the subject of recent investigations in isolated osteoclasts. Such studies have shown a possible involvement of distinguishable receptor subtypes, the occupancy of which may activate at least two types of triggering mechanism. It is likely that an eventual influence on motility properties through G protein mediation accounts for the actions of this hormone and of related peptides such as amylin and CGRP at the cellular level. Similar pathways may contribute to shorter range modulation of osteoclast activity by increases in ambient Ca2+. Finally, there is recent evidence for a contribution of endothelial cell-derived product to osteoclast regulation.
Similar articles
-
Cellular biology of bone resorption.Biol Rev Camb Philos Soc. 1993 May;68(2):197-264. doi: 10.1111/j.1469-185x.1993.tb00996.x. Biol Rev Camb Philos Soc. 1993. PMID: 8504194 Review.
-
Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts.Exp Physiol. 1993 Mar;78(2):183-96. doi: 10.1113/expphysiol.1993.sp003679. Exp Physiol. 1993. PMID: 8385961
-
Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.J Cell Physiol. 1998 Sep;176(3):537-44. doi: 10.1002/(SICI)1097-4652(199809)176:3<537::AID-JCP10>3.0.CO;2-X. J Cell Physiol. 1998. PMID: 9699506
-
The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.Bone. 2008 Nov;43(5):813-8. doi: 10.1016/j.bone.2008.07.003. Epub 2008 Jul 18. Bone. 2008. PMID: 18687416 Review.
-
Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.Endocrinology. 1995 Jan;136(1):124-31. doi: 10.1210/endo.136.1.7828521. Endocrinology. 1995. PMID: 7828521
Cited by
-
The effects of low-level laser therapy on orthodontically induced root resorption.Lasers Med Sci. 2015 Nov;30(8):2067-76. doi: 10.1007/s10103-015-1717-6. Epub 2015 Jan 30. Lasers Med Sci. 2015. PMID: 25633918
-
The elevated expression of calcitonin receptor by cells recruited into the endothelial layer and neo-intima of atherosclerotic plaque.Histochem Cell Biol. 2009 Aug;132(2):181-9. doi: 10.1007/s00418-009-0600-6. Epub 2009 Apr 29. Histochem Cell Biol. 2009. PMID: 19404669
-
Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma.Ther Adv Med Oncol. 2020 Dec 18;12:1758835920978110. doi: 10.1177/1758835920978110. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33425026 Free PMC article. Review.
-
Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa.Bone. 2010 Mar;46(3):796-800. doi: 10.1016/j.bone.2009.11.014. Epub 2009 Nov 18. Bone. 2010. PMID: 19931436 Free PMC article.
-
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo.J Cell Biol. 2004 Feb 16;164(4):509-14. doi: 10.1083/jcb.200312135. J Cell Biol. 2004. PMID: 14970190 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous